Key result
Warfarin in mechanical valve patients yields a ~5% annual bleeding rate with very low thromboembolism.
Why the study?
Anticoagulation with vitamin K antagonists is recommended to prevent thromboembolism in patients with mechanical heart valves, but this treatment carries a notable risk of bleeding.
Cohort (n=409)
In patients with mechanical heart valves on warfarin achieving a 68% TTR, bleeding complications occurred much more frequently than thromboembolic events over 12 months.
Answers are grounded in this paper and cite their sources.
Bleeding predominated over thromboembolism in this cohort; leaves open whether TTR optimization reduces events in mechanical valve patients.
Anticoagulation with vitamin K antagonists is recommended for prevention of thromboembolism in patients with mechanical heart valves. However, this treatment carries a notable risk of bleeding. We performed a retrospective analysis of patients with mechanical heart valves who were anticoagulated with warfarin, extracting the number and type of mechanical heart valves and their time in therapeutic range (TTR) for various recommended international normalised ratio (INR) ranges. Following this, we carried out a prospective study, over two separate six-month periods, identifying those with mechanical heart valves who sustained a bleeding or thromboembolic event. We identified 409 patients with mechanical heart valves with an overall TTR of 68%. Over 12 months, we recorded 32 possible bleeding incidents in 22 patients. There was one thromboembolic event during this period, specifically a cerebrovascular event. In conclusion, while our data indicate an elevated risk of bleeding, additional larger studies are needed to better understand bleeding risks across different demographic groups.
No takes yet. Share an insight, caveat, or question.
Glatzel et al. (2026) conducted a cohort in Mechanical heart valves (n=409). Warfarin anticoagulation was evaluated on Bleeding or thromboembolic events over 12 months. Warfarin in 409 mechanical valve patients resulted in 32 bleeding incidents in 22 patients and 1 thromboembolic event over 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: